S

SpringWorks Therapeutics
D

SWTX

39.030
USD
2.75
(7.58%)
مغلق
حجم التداول
47,047
الربح لكل سهم
-3
العائد الربحي
-
P/E
-10
حجم السوق
2,903,301,309
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AKRO
    -1.660
    (-5.58%)
    28.070 USD
    B
    BEAM
    -2.275
    (-8.65%)
    24.035 USD
    M
    MGTX
    -0.18000
    (-2.71%)
    6.47000 USD
    P
    PRVB
    -0.075
    (-0.31%)
    23.870 USD
    R
    RAPT
    -0.18000
    (-14.06%)
    1.10000 USD
    S
    SWAV
    0
    (0%)
    0.000000 USD
    V
    VYGR
    -0.57000
    (-9.18%)
    5.64000 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    المزيد
الأخبار

العنوان: SpringWorks Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several otherprograms addressing highly prevalent, genetically defined cancers.